Tympa Health Technologies, a London, UK-based digital health company, raised $8M in Seed funding.
The round was led by Maurice Ferre and Arjun Desai with participation from Jim Breyer, Anil Sethi, Martin Varsavsky, Carlos Gallardo, Fred Moll, Elan Katz, Manny Kadre and Imran Hakim. TympaHealth will also be appointing Arjun Desai and Karin Ajmani to their board of directors.
The company intends to use the funds to accelerate its expansion across the U.K., Europe & U.S.
Founded by CEO Dr. Krishan Ramdoo, TympaHealth is a digital health company that uses patented technology to allow for comprehensive hearing health assessments to be performed in point-of-care settings, enabling earlier disease detection and access to cost-effective care. By combining proprietary hardware and AI-enabled software, TympaHealth created a hearing assessment platform available to patients outside traditional primary or secondary care settings, like pharmacies, retail stores, and assisted living facilities. Fully portable and intuitive, within a few minutes, the point of care tool provides patients (and their providers) with the information to detect disease and manage their hearing health through high-resolution ear drum visualization, ear wax removal and a real-time screening audiogram.
The system is CE marked and FDA registered.
FinSMEs
20/02/2022